Sublingual Sufentanil May Reduce Risk for Psychiatric Sequalae and Chronic Pain Following Combat Trauma: Editorial for the Newest Battlefield Opioid, Sublingual Sufentanil

Mil Med. 2022 Jul 1;187(7-8):217-218. doi: 10.1093/milmed/usac053.
No abstract available

Publication types

  • Letter

MeSH terms

  • Analgesia, Patient-Controlled
  • Analgesics, Opioid / therapeutic use
  • Chronic Pain* / drug therapy
  • Chronic Pain* / etiology
  • Humans
  • Pain, Postoperative
  • Sufentanil*

Substances

  • Analgesics, Opioid
  • Sufentanil